Therefore, RCC2 plays a vital role in tumor proliferation, tumorigenicity, and promotes radioresistance by activating transcription of DNA methyltransferase 1 (DNMT1) through a p-STAT3 dependent pathway (Figure 3). Here, RCC2 is linked to neoplasm.